Gómez VI, Franyuti KG, Hornelas VA

Language: Spanish
References: 9
Page: 285-287
PDF size: 125.40 Kb.

ABSTRACT

Methemoglobinemia is a clinical entity caused by oxidation of hemoglobin (Hb) specifically heme, transforming iron from a ferrous state (Fe²⁺) to a ferric state (Fe³⁺⁺⁺), resulting in methemoglobin (MetHb), which is not capable of bonding with oxygen (O₂), and therefore cannot transport it, conditioning tissue irrigation. Hb may oxidize due to variable expression genetic abnormalities expression, or more frequently, as an adverse effect related to exogenous substances, such as dapsone. This work describes the clinical picture, diagnosis and treatment of a patient with metahemoglobinemia-acquired secondary to dapsone overdose.

REFERENCES

1. Versmold H, Riegel KP. The effect of methemoglobin on the equilibrium between oxygen and the hemoglobins F & A1 at different concentrations of 2,3-diphosphoglycerate. Pediatr Res. 1974;8(2):140.

2. Misra HP, Fridovich I. The generation of superoxide radical during the autoxidation of hemoglobin. J Biol Chem. 1972;247(21):6960-6962.

3. Ward KE, McCarthy MW. Dapsone-induced methemoglobinemia. Ann Pharmacother. 1998;32(5):549-553.

4. Toker I, Yesilaras M, Tur FC, Toktas R. Methemoglobinemia caused by dapsone overdose: Which treatment is best? Turk J Emerg Med. 2016;15(4):182-184.

5. Lata K, Janardhanan R. Methemoglobinemia: a diagnosis not to be missed. Am J Med. 2015;128(10):e45-e46.

6. Zhu YI, Stiller MJ. Dapsone and sulfones in dermatology: overview and update. J Am Acad Dermatol. 2001;45(3):420-434.

7. Wozel VE. Innovative use of dapsone. Dermatol Clin. 2010;28(3):599-610.

8. Burke P, Jahangir K, Kolber MR. Dapsone-induced methemoglobinemia: case of the blue lady. Can Fam Physician. 2013;59(9):958-961.

9. Esbenshade AJ, Ho RH, Shintani A, Zhao Z, Smith LA, Friedman DL. Dapsone-induced methemoglobinemia: a dose-related occurrence? Cancer. 2011;117(15):3485-3492.